Grains of Paradise
7 benefits mapped to clinical evidence across supplements.
Dose per serving from products
31 products in our catalogue print how much Grains of Paradise a serving holds.
Most common: 25 mg to 50 mg, 65% of 31 products.
| Dose per serving | Products |
|---|---|
| 5 mg or less | 2 |
| 5 mg to 10 mg | 0 |
| 10 mg to 25 mg | 4 |
| 25 mg to 50 mg | 20 |
| 50 mg to 100 mg | 0 |
| 100 mg to 250 mg | 4 |
| over 250 mg | 1 |
Benefit Evidence
Research sources
Body composition (1)
- Aframomum melegueta Seed Extract with Standardized Content of 6-Paradol Reduces Visceral Fat and Enhances Energy Expenditure in Overweight Adults - A Randomized Double-Blind, Placebo-Controlled Clinical Study
PubMed ID: 36329722
RCT showed significant reductions in visceral fat area and body weight, directly improving body composition.
Cholesterol (1)
- Aframomum melegueta Seed Extract with Standardized Content of 6-Paradol Reduces Visceral Fat and Enhances Energy Expenditure in Overweight Adults - A Randomized Double-Blind, Placebo-Controlled Clinical Study
PubMed ID: 36329722
Significant visceral fat reduction implies potential improvement in lipid/metabolic risk, though direct lipid measures were not reported.
Energy & Fatigue (1)
- Aframomum melegueta Seed Extract with Standardized Content of 6-Paradol Reduces Visceral Fat and Enhances Energy Expenditure in Overweight Adults - A Randomized Double-Blind, Placebo-Controlled Clinical Study
PubMed ID: 36329722
12‑week RCT reported ~18.6% increase in resting energy expenditure, a direct measure relevant to energy availability.
Fat burn (1)
- Aframomum melegueta Seed Extract with Standardized Content of 6-Paradol Reduces Visceral Fat and Enhances Energy Expenditure in Overweight Adults - A Randomized Double-Blind, Placebo-Controlled Clinical Study
PubMed ID: 36329722
Marked ↑ (~18.6%) in resting EE over 12 weeks indicates sustained thermogenic activation.
Metabolism (1)
- Aframomum melegueta Seed Extract with Standardized Content of 6-Paradol Reduces Visceral Fat and Enhances Energy Expenditure in Overweight Adults - A Randomized Double-Blind, Placebo-Controlled Clinical Study
PubMed ID: 36329722
Robust 12‑week RCT evidence for increased EE and reductions in visceral fat and body weight, supporting metabolic health.
Weight management (1)
- Aframomum melegueta Seed Extract with Standardized Content of 6-Paradol Reduces Visceral Fat and Enhances Energy Expenditure in Overweight Adults - A Randomized Double-Blind, Placebo-Controlled Clinical Study
PubMed ID: 36329722
12‑week RCT demonstrated clinically meaningful weight loss (~4.07 kg) and decreased visceral fat vs placebo.
Wellbeing (1)
- Aframomum melegueta Seed Extract with Standardized Content of 6-Paradol Reduces Visceral Fat and Enhances Energy Expenditure in Overweight Adults - A Randomized Double-Blind, Placebo-Controlled Clinical Study
PubMed ID: 36329722
Comprehensive 12‑week benefits (↑ EE, weight and visceral fat loss) likely contribute to overall wellbeing.
Similar by evidence
Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.
Products with Grains of Paradise
Search all45 products whose verified label declares Grains of Paradise — not every bottle that mentions it in a title.
Being studied right now
Recruiting clinical trials registered on ClinicalTrials.gov. A trial in progress has no result yet — this is what the field is asking, not what it found.